BG62272B1 - Използване на 4-аминопиридин в терапията на неврологичнизаболявания - Google Patents

Използване на 4-аминопиридин в терапията на неврологичнизаболявания Download PDF

Info

Publication number: BG62272B1
Authority: BG; Bulgaria
Prior art keywords: patients; infusion; aminopyridine; effects; patient
Prior art date: 1992-12-18

Application number

BG99047A

Other languages

Bulgarian (bg)

English (en)

Other versions

BG99047A (bg

Inventor

Robert R. Hansebout

Andrew R. Blight

Original Assignee

Canadian Spinal Research Organization

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1992-12-18

Filing date

1994-09-16

Publication date

1999-07-30

1994-09-16 Application filed by Canadian Spinal Research Organization filed Critical Canadian Spinal Research Organization

1995-06-30 Publication of BG99047A publication Critical patent/BG99047A/bg

1999-07-30 Publication of BG62272B1 publication Critical patent/BG62272B1/bg

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids

Landscapes

Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Neurology (AREA)
Epidemiology (AREA)
Bioinformatics & Cheminformatics (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Pain & Pain Management (AREA)
Orthopedic Medicine & Surgery (AREA)
Physical Education & Sports Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Pyridine Compounds (AREA)

BG99047A 1992-12-18 1994-09-16 Използване на 4-аминопиридин в терапията на неврологичнизаболявания BG62272B1 (bg)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
CA002085785A CA2085785C (en)	1992-12-18	1992-12-18	The use of 4-aminopyridine in the treatment of a neurological condition
PCT/CA1993/000554 WO1994014439A1 (en)	1992-12-18	1993-12-20	The use of 4-aminopyridine in the treatment of a neurological condition

Publications (2)

Publication Number	Publication Date
BG99047A BG99047A (bg)	1995-06-30
BG62272B1 true BG62272B1 (bg)	1999-07-30

Family

ID=4150879

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
BG99047A BG62272B1 (bg)	1992-12-18	1994-09-16	Използване на 4-аминопиридин в терапията на неврологичнизаболявания

Country Status (19)

Country	Link
US (1)	US5545648A (no)
EP (1)	EP0626848B1 (no)
JP (1)	JP3474569B2 (no)
KR (1)	KR100301415B1 (no)
AT (1)	ATE241981T1 (no)
AU (1)	AU676251B2 (no)
BG (1)	BG62272B1 (no)
BR (1)	BR9305909A (no)
CA (1)	CA2085785C (no)
CZ (1)	CZ284441B6 (no)
DE (1)	DE69333014T2 (no)
ES (1)	ES2199957T3 (no)
FI (1)	FI943765A (no)
HU (1)	HU219583B (no)
NO (2)	NO308644B1 (no)
NZ (1)	NZ258844A (no)
RU (1)	RU2160590C2 (no)
SK (1)	SK280922B6 (no)
WO (1)	WO1994014439A1 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5792743A (en) *	1995-04-19	1998-08-11	Acorda Therapeutics	Method for promoting neural growth comprising administering a soluble neural cell adhesion molecule
JPH09315972A (ja) *	1996-03-22	1997-12-09	Chugai Pharmaceut Co Ltd	脊髄損傷治療剤
US6190370B1 (en)	1997-07-25	2001-02-20	Arrow International, Inc.	Devices, systems and methods for determining proper placement of epidural catheters
US7582680B1 (en)	1998-11-12	2009-09-01	Purdue Research Foundation	Methods and compositions for treating mammalian spinal cord injuries
US6503931B1 (en) *	1999-02-09	2003-01-07	The Uab Research Foundation	Use of 4-amino pyridine for treatment of peripheral neuropathies
NO324322B1 (no)	2001-02-26	2007-09-24	Dynea Oy	Anvendelse av herder samt fremgangsmate ved liming
NZ543953A (en)	2001-04-24	2007-04-27	Univ Chicago	Method and compositions for treating mammalian nerve tissue injuries
US20040047843A1 (en) *	2002-02-12	2004-03-11	Uab Research Foundation	Method for spinal cord reconnection
US7244748B2 (en) *	2002-12-06	2007-07-17	Purdue Research Foundation	Pyridines for treating injured mammalian nerve tissue
US8729107B2 (en) *	2002-12-06	2014-05-20	Purdue Research Foundation	Pyridines for treating injured mammalian nerve tissue
JP4533590B2 (ja) *	2003-02-28	2010-09-01	ファイザー株式会社	脊髄損傷患者における疼痛又は痙性軽減用医薬組成物
US20050192321A1 (en) *	2003-09-15	2005-09-01	Meythaler Jay M.	Treatment of neuropathy with rapid release aminopyridine
US8007826B2 (en) *	2003-12-11	2011-08-30	Acorda Therapeutics, Inc.	Sustained release aminopyridine composition
US8354437B2 (en)	2004-04-09	2013-01-15	Acorda Therapeutics, Inc.	Method of using sustained release aminopyridine compositions
AU2012211101B2 (en) *	2011-01-28	2017-04-20	Acorda Therapeutics, Inc.	Use of potassium channel blockers to treat cerebral palsy
US8924325B1 (en) *	2011-02-08	2014-12-30	Lockheed Martin Corporation	Computerized target hostility determination and countermeasure
TWI592156B (zh) *	2011-10-04	2017-07-21	艾可達醫療公司	使用胺基吡啶以治療與中風有關之感覺動作損傷之方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4508715A (en) *	1981-07-01	1985-04-02	University Of Georgia Research Foundation, Inc.	Antagonism of central nervous system drugs by the administration of 4-aminopyridine alone or in combination with other drugs
EP0408650A1 (en) *	1988-04-08	1991-01-23	Massachusetts Institute Of Technology	Method and composition for treating neurological disorders
IE82916B1 (en) *	1990-11-02	2003-06-11	Elan Corp Plc	Formulations and their use in the treatment of neurological diseases

1992
- 1992-12-18 CA CA002085785A patent/CA2085785C/en not_active Expired - Lifetime
1993
- 1993-12-20 ES ES94902578T patent/ES2199957T3/es not_active Expired - Lifetime
- 1993-12-20 AU AU56911/94A patent/AU676251B2/en not_active Expired
- 1993-12-20 RU RU94041207/14A patent/RU2160590C2/ru active
- 1993-12-20 EP EP94902578A patent/EP0626848B1/en not_active Expired - Lifetime
- 1993-12-20 KR KR1019940702838A patent/KR100301415B1/ko not_active IP Right Cessation
- 1993-12-20 HU HU9402647A patent/HU219583B/hu unknown
- 1993-12-20 US US08/290,757 patent/US5545648A/en not_active Expired - Lifetime
- 1993-12-20 SK SK969-94A patent/SK280922B6/sk not_active IP Right Cessation
- 1993-12-20 JP JP51463794A patent/JP3474569B2/ja not_active Expired - Lifetime
- 1993-12-20 BR BR9305909A patent/BR9305909A/pt not_active Application Discontinuation
- 1993-12-20 WO PCT/CA1993/000554 patent/WO1994014439A1/en active IP Right Grant
- 1993-12-20 DE DE69333014T patent/DE69333014T2/de not_active Expired - Lifetime
- 1993-12-20 CZ CZ942254A patent/CZ284441B6/cs not_active IP Right Cessation
- 1993-12-20 AT AT94902578T patent/ATE241981T1/de not_active IP Right Cessation
- 1993-12-20 NZ NZ258844A patent/NZ258844A/en not_active IP Right Cessation
1994
- 1994-08-16 FI FI943765A patent/FI943765A/fi unknown
- 1994-08-17 NO NO943049A patent/NO308644B1/no not_active IP Right Cessation
- 1994-09-16 BG BG99047A patent/BG62272B1/bg unknown
2012
- 2012-01-30 NO NO2012003C patent/NO2012003I2/no unknown

Also Published As

Publication number	Publication date
HUT68171A (en)	1995-05-29
SK96994A3 (en)	1995-04-12
FI943765A (fi)	1994-10-14
NZ258844A (en)	1997-04-24
WO1994014439A1 (en)	1994-07-07
RU2160590C2 (ru)	2000-12-20
DE69333014T2 (de)	2004-05-06
HU219583B (hu)	2001-05-28
JP3474569B2 (ja)	2003-12-08
NO943049D0 (no)	1994-08-17
NO2012003I2 (no)	2013-02-18
CZ225494A3 (en)	1995-03-15
KR950700062A (ko)	1995-01-16
FI943765A0 (fi)	1994-08-16
EP0626848B1 (en)	2003-06-04
HU9402647D0 (en)	1994-11-28
BG99047A (bg)	1995-06-30
NO2012003I1 (no)	2012-02-13
CZ284441B6 (cs)	1998-11-11
ATE241981T1 (de)	2003-06-15
CA2085785C (en)	2005-03-15
AU5691194A (en)	1994-07-19
CA2085785A1 (en)	1994-06-19
BR9305909A (pt)	1997-10-21
NO308644B1 (no)	2000-10-09
NO943049L (no)	1994-10-17
SK280922B6 (sk)	2000-09-12
JPH08504772A (ja)	1996-05-21
DE69333014D1 (de)	2003-07-10
US5545648A (en)	1996-08-13
AU676251B2 (en)	1997-03-06
EP0626848A1 (en)	1994-12-07
ES2199957T3 (es)	2004-03-01
RU94041207A (ru)	1996-06-20
KR100301415B1 (ko)	2001-11-22

Similar Documents

Publication	Publication Date	Title
Hansebout et al.	1993	4-Aminopyridine in chronic spinal cord injury: a controlled, double-blind, crossover study in eight patients
Newsom-Davis et al.	1993	Immunological associations of acquired neuromyotonia (Isaacs' syndrome) Report of five cases and literature review
Hayes et al.	1993	Preclinical trial of 4-aminopyridine in patients with chronic spinal cord injury
BG62272B1 (bg)	1999-07-30	Използване на 4-аминопиридин в терапията на неврологичнизаболявания
Potter et al.	1998	Randomized double-blind crossover trial of fampridine-SR (sustained release 4-aminopyridine) in patients with incomplete spinal cord injury
Hallett et al.	1979	Cortical reflex myoclonus
Curt et al.	1999	Electrophysiological recordings in patients with spinal cord injury: significance for predicting outcome
STRUPPLER et al.	1963	Local tetanus in man: its clinical and neurophysiological characteristics
Eisen et al.	1974	Peripheral nerve function in long‐term therapy with diphenylhydantoin: A clinical and electrophysiologic correlation
Donovan et al.	2000	Intravenous infusion of 4-AP in chronic spinal cord injured subjects
Mamoli et al.	1977	Electrophysiological studies on the “stiff-man” syndrome
Ashby et al.	1973	“Presynaptic” inhibition in spasticity and the effect of β (4-chlorophenyl) GABA
Glikson et al.	1991	The influence of pyridostigmine administration on human neuromuscular functions—studies in healthy human subjects
Bowden et al.	2009	Clinical and Neurophysiologie Assessment of Strength and Spasticity During Intrathecal Baclofen Titration in Incomplete Spinal Cord Injury: Single-Subject Design
Cottingham et al.	1985	The effect of subcutaneous nerve stimulation (SCNS) on pain associated with osteoarthritis of the hip
Öge et al.	2000	Neuromuscular consequences of prolonged hunger strike: an electrophysiological study
Losseff et al.	1995	The medical management of increased tone
Perkin et al.	1976	A trial of brolitene in the treatment of spasticity.
Van den Bergh et al.	1983	Motor neuron rigidity: an electrophysiological, pharmacological and pathological study
Bergh et al.	1983	Motor neuron rigidity
WARNER	0	Table Nerve Conduction Studies
Devi	0	ACUTE SYMMETRICAL MOTOR NEUROPATHY IN DIABETES MELLITUS
Vijayalakshmi et al.	1995	PS-50-9 Confirmatory in vivo electrodiagnostic and electromyographic studies for a new neuromuscular junctional blocking agent from Indian medicinal plant cleistanthus collinus
Patil	2002	Management of Pain Associated with Peripheral Neuropathy
Botelho et al.	0	Safety profile of combined Botulinum toxin-A & phenol blockade in adults with spasticity: A retrospective analysis of 134 post-stroke patients [k1]